Bid Banana
PricingBid helpAPILog inStart free trial
Log inStart free trial

Before you respond

  • Federal grantsHow to Find Grants for Nonprofits
  • Healthcare RFPsHealthcare and Medical Services Bids and Bidding Guide
  • How to apply for a grantGrant Applications vs. RFPs: Writing Differences Explained
More healthcare and medical services bids →Must-win bid? Bring in The Bid Lab →
Bid Banana
SearchPricingBid helpBrowse bidsAPISupportFAQPrivacy PolicyTerms of UseAI Use Policy

This website and its content is copyright of The Bid Lab © 2026. The Bid Lab is a trademark of Bid Lab, LLC. All rights reserved.

  1. Bid Banana
  2. ›Bids
  3. ›Federal
  4. ›Natural History of Disorders Screenable in the Newborn…

U.S. National Institutes of Health·United States of America

Natural History of Disorders Screenable in the Newborn Period (R01 Clinical Trial Optional)

Closes 1/7/2028$100k – $500kGrants Notice
Get bids like this by emailBid source

Description

The purpose of this Notice of Funding Opportunity (NOFO) is to encourage applications that will expand knowledge of the natural history of disorders that currently are, or may become, part of statewide newborn screening programs. This includes characterization of the sequence and timing of symptom development, establishment of genotype-phenotype correlations, and identification of modifying genetic, epigenetic, or environmental factors. The goal is to facilitate appropriate interventions for infants identified by newborn screening and to improve diagnostic accuracy, clinical trials, and treatment outcomes. • The opportunity is open to various applicant types, including public and state-controlled institutions of higher education, non-profits, small businesses, and others. • The funding instrument is a grant, and the funding activity categories are Health and Income Security and Social Services. • The expected application count is 100, and the expected application size is 0. • The opportunity is electronic and requires the use of the eRA Service Desk for support.

Attached files

Contact

[email protected]

(301) 402-2541

Key dates

Opened
2/8/2021
Closes
1/7/2028

Last updated

Details

Type
Grants Notice
Industry
Healthcare and Medical Services
NAICS
541710
Solicitation №
PAR-25-227

Budget estimate

$100,000 – $500,000

The budget for this opportunity is not explicitly stated, but based on the information provided, it can be estimated that the grant amount will be in the range of $100,000 to $500,000. This estimate is based on the fact that the opportunity is a grant and the funding activity categories are Health and Income Security and Social Services. The actual budget will depend on various factors, including the number of applications received, the quality of the applications, and the availability of funds.

AI estimate from the solicitation

Similar opportunities

Matched by Bid Banana AI™

Bid Banana · 1.6M+ bids and awards 🍌

You found this one. Bid Banana has 1.6M+ bids and awards.

You found this bid by looking. Bid Banana searches open government bids across all 50 states, updated daily, so you stop hunting: save a search once and we email you your new matches, daily or weekly.

1.6M+
bids & awards
All 50
states
4,000+
agencies
Start your 7-day free trial

Plans from $49.99/month. Cancel anytime, no setup fees.

Built by The Bid Lab, answering RFPs since 2017.

U.S. National Institutes of Health·United States of America

Top match · 86%

Innovative Screening Approaches and Therapies for Screenable Disorders in Newborns (R01 - Clinical Trial Optional)

Closes 11/16/2027Opened 12/2/2024

U.S. National Institutes of Health·United States of America

85% match

Biological Testing Facility for Contraception & Reproductive Health (X01 Clinical Trial Not Allowed)

Closes 5/7/2029Opened 9/15/2025

U.S. National Institutes of Health·United States of America

84% match

Early-Onset Cancers: Investigating Etiology, Mechanisms, and Early Detection Strategies (RP1 Clinical Trials Optional)

Closes 10/11/2029Opened 3/10/2026

U.S. National Institutes of Health·United States of America

84% match

Early Immune System Development and Ontogeny (R01 Clinical Trial Optional)

Closes 11/5/2028Opened 12/30/2024

U.S. National Institutes of Health·United States of America

84% match

Innovative Screening Approaches and Therapies for Screenable Disorders in Newborns (R21 - Clinical Trial Optional)

Closes 11/16/2027Opened 12/2/2024

U.S. National Institutes of Health·United States of America

83% match

Focused Technology Research and Development (R01 Clinical Trial Not Allowed)

Closes 1/7/2028Opened 3/21/2022

U.S. National Institutes of Health·United States of America

83% match

First in Human and Early Stage Clinical Trials of Novel Investigational Drugs or Neuromodulatory Device-based Interventions for Psychiatric Disorders (U01 Clinical Trial Required)

Closes 10/15/2027Opened 11/26/2024

U.S. National Institutes of Health·United States of America

83% match

Prevention and Intervention Approaches for Fetal Alcohol Spectrum Disorders (R61/R33 Clinical Trial Optional)

Closes 11/17/2026Opened 11/22/2023

U.S. National Institutes of Health·United States of America

83% match

Modular R01s in Cancer Control and Population Sciences (R01 Clinical Trial Optional)

Closes 2/11/2028Opened 11/7/2024

U.S. Food and Drug Administration·United States of America

83% match

Reissue of RFA-FD-23-001- Clinical Studies of Orphan Products Addressing Unmet Needs of Rare Diseases (R01 Clinical Trials Required)

Closes 5/16/2028Opened 7/11/2025

U.S. National Institutes of Health·United States of America

82% match

Screening and Functional Validation of Genomic Variants Associated with Human Congenital Anomalies (R01 Clinical Trial Not Allowed)

Closes 1/7/2028Opened 10/30/2024

U.S. National Institutes of Health·United States of America

82% match

Preclinical Proof of Concept Studies for Rare Diseases (R21 Clinical Trial Not Allowed)

Closes 7/2/2027Opened 7/5/2023

U.S. National Institutes of Health·United States of America

82% match

Discovery of in vivo Chemical Probes for the Nervous System (R01 Clinical Trial Not Allowed)

Closes 3/5/2027Opened 9/29/2025

U.S. National Institutes of Health·United States of America

82% match

NIH Research Program Projects (Parent P01 Clinical Trial Optional)

Closes 5/25/2029Opened 2/11/2026

U.S. National Institutes of Health·United States of America

82% match

NCCIH Natural Product Early Phase Clinical Trial Phased Innovation Award (R61/R33 Clinical Trial Required)

Closes 11/13/2026Opened 2/1/2024

U.S. National Institutes of Health·United States of America

81% match

Pilot Health Services and Economic Research on the Treatment of Drug, Alcohol, and Tobacco Use Disorders (R34 Clinical Trial Optional)

Closes 10/27/2027Opened 5/11/2021

U.S. National Institutes of Health·United States of America

81% match

NHLBI Clinical Trial Pilot Studies (R34 Clinical Trial Optional)

Closes 3/16/2027Opened 11/3/2023

U.S. National Institutes of Health·United States of America

81% match

Leveraging Network Infrastructure to Conduct Innovative Research for Women, Children, Pregnant and Lactating Women, and Persons with Disabilities (UG3/UH3 - Clinical Trial Optional)

Closes 11/15/2027Opened 12/16/2024

U.S. Food and Drug Administration·United States of America

81% match

Reissue of RFA-FD-22-001 - Efficient and Innovative Natural History Studies Addressing Unmet Needs in Rare Diseases (R01 Clinical Trials Optional)

Closes 2/8/2028Opened 7/11/2025

U.S. National Institutes of Health·United States of America

81% match

Prevention and Intervention Approaches for Fetal Alcohol Spectrum Disorders (R34 Clinical Trial Optional)

Closes 1/7/2027Opened 11/22/2023

U.S. National Institutes of Health·United States of America

81% match

Effectiveness Trials for Post-Acute Interventions and Services to Optimize Longer-term Outcomes (R01 Clinical Trial Required)

Closes 1/7/2028Opened 4/1/2021

U.S. National Institutes of Health·United States of America

81% match

Dissemination and Implementation Research in Health (R01 Clinical Trial Optional)

Closes 1/7/2028Opened 5/10/2022

U.S. National Institutes of Health·United States of America

81% match

INCLUDE Project: Clinical Trials Phased Awards for Down syndrome Research (R61/R33 Clinical Trial Required)

Closes 6/15/2028Opened 9/25/2025

U.S. National Institutes of Health·United States of America

81% match

Accelerating the Pace of Substance Use Research Using Existing Data (R01 Clinical Trial Not Allowed)

Closes 12/3/2027Opened 12/5/2024

U.S. National Institutes of Health·United States of America

81% match

Collaborative Initiative on Fetal Alcohol Spectrum Disorders (CIFASD), Research Program (U19 Clinical Trial Optional)

Closes 9/24/2027Opened 10/6/2026